Grassley seeks Commissioner
This article was originally published in The Tan Sheet
Executive Summary
"The FDA has struggled with temporary leadership for too long," Sen. Charles Grassley (R-Iowa) asserts in a Feb. 3 letter to President Bush's Chief of Staff Andrew Card. "I reiterate my request for the President to nominate a permanent Commissioner to the FDA as soon as possible," states Grassley, who chairs the Senate Finance Committee. Grassley first called for a leader "who can be totally dedicated to the job" when NCI Director Andrew Von Eschenbach assumed the position of acting commissioner in September (1"The Tan Sheet" Oct. 3, 2005, p. 6). FDA "needs and deserves a full-time, permanent Commissioner with the authority to address the cultural, structural and scientific challenges that have plagued the agency," Grassley states. "As has been overwhelmingly evident in the past few years, there are too many concerns and questionable practices that would require anything less"...
You may also be interested in...
Acting FDA Head Von Eschenbach Takes A Step Back At NCI
FDA Acting Commissioner Andrew von Eschenbach's decision to step away from day-to-day management duties at the National Cancer Institute follows a week of criticism from Capitol Hill related to his dual role
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.